Your browser doesn't support javascript.
loading
Retinoblastoma in Jordan: an epidemiological study [2006-2010]
Hematology, Oncology and Stem Cell Therapy. 2011; 4 (3): 132-135
in English | IMEMR | ID: emr-109087
ABSTRACT
The epidemiological characteristics of retinoblastoma have been extensively studied in developed countries, however epidemiological data is scarce in the Middle East. We present a detailed epidemiological analysis of retinoblastoma in Jordan in an attempt to aid national and regional strategies for improved cancer surveillance and control. Retrospective review of retinoblastoma cases presenting to the sole and exclusive ocular oncology referral center in Jordan. Forty children [59 eyes] presenting with clinically and/or histologically confirmed retinoblastomas were treated at King Hussein Cancer Center [Amman, Jordan] between January 2006 and December 2010. This case series included 28 boys and 12 girls. Data relating to age at diagnosis, laterality, gender, treatment modality and survival were recorded. The mean age-adjusted incidence of retinoblastoma in Jordan was 9.32 cases per million children per year for children aged 0-5 years. The male female ratio was 2.31. Bilateral cases were encountered in 19 patients [47.5%] while 21 patients [52.5%] harbored unilateral retinoblastoma. At the time of follow-up, 38 patients [95%] were alive. Overall, 40 eyes [67.8%] were successfully preserved without the need for enucleation. The national epidemiological data gathered in this study indicates that the incidence of retinoblastoma in Jordan is similar to that reported in various countries of the world. Jordanian boys, however, are at significantly higher risk for developing retinoblastoma than age-matched girls. Furthermore, Jordanian patients are more likely to harbor bilateral retinoblastoma
Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Hematol. Oncol. Stem Cell Ther. Year: 2011

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Hematol. Oncol. Stem Cell Ther. Year: 2011